Brookline Capital Acquisition offered 5 million units at $10 each to raise $50 million in an IPO.
Brookline is targeting life science companies in the United States and Europe.
The SPAC is led by CEO and Chairman Samuel Wertheimer, President Scott Katzmann, and CFO Patrick Sturgeon.
Shares of the new SPAC begin trading today on the Nasdaq under BCACU. Read more.
